Viewing nowRoglic (Glimepiride) Tablets
Glimepiride 2mg
Tablet · Prescription medication
Medica Korea Co., Ltd.

MFDS item code 200401371 · Notified 2004.04.07 · Insurance code 646000450
Improvement of blood glucose control in type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to help control blood sugar in patients with type 2 diabetes. It can be administered alone or in combination with insulin when blood sugar control is inadequate with oral hypoglycemic agents. It is also used in combination with metformin when sulfonylureas or metformin monotherapy is ineffective. This medication is effective in improving blood sugar control and is used in the treatment of diabetes.
Individualize the dose for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with an increase to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose-equivalence relationship between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previously administered medicine. 4) Dose monitoring While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after successful initial management with sulfonylurea medicines. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical attention and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylurea agents such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate caution should be exercised.
This medication should not be used in patients with type 1 diabetes, diabetic ketoacidosis, or those in a comatose state. It should not be administered to individuals with an allergy to this drug or its components, or similar medications. There is no experience with use in patients with severe liver or kidney dysfunction, so switching to insulin therapy is recommended. It is safer for pregnant women, women of childbearing potential, and nursing mothers to avoid this medication. Insulin therapy is recommended for patients with severe infections, pre- and post-surgical states, or severe trauma. Patients with gastrointestinal disturbances such as diarrhea or vomiting may have inadequate food absorption, leading to a risk of hypoglycemia, thus caution is advised. During the first week of administration, the risk of hypoglycemia is high, so blood sugar should be monitored closely. Particularly careful monitoring is required for the elderly, patients with poor nutritional status, those with irregular meal patterns, incongruent exercise and carbohydrate intake, changes in eating habits, frequent alcohol consumption, patients with decreased kidney and liver function, and patients who have overdosed on this medication. Moreover, caution is needed for patients with endocrine disorders such as thyroid or adrenal disease or those taking other medications. Due to its blood sugar-lowering action, this medication can cause hypoglycemic symptoms. Symptoms of hypoglycemia may include headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and decreased consciousness, and in severe cases, may lead to coma. Additionally, symptoms such as blurred vision, gastrointestinal disturbances, abnormal liver function, blood abnormalities, and allergic reactions may occur, and immediate consultation with medical personnel is required if any abnormal symptoms appear. While taking this medication, regular meals and exercise should be maintained, and blood sugar control should be monitored consistently. It is important to be prepared to quickly counteract hypoglycemia by consuming foods containing sugars. Also, if blood sugar control becomes difficult due to stressful situations, surgeries, or infections, transitioning to insulin therapy may be necessary. This medication can interact with other medications, so patients must inform their physician or pharmacist about any other medications being taken. Particularly, caution should be exercised when co-administering with medications metabolized in the liver, as this may affect blood sugar control. Pregnant or nursing women should consider insulin therapy instead of this medication as it may affect the fetus or newborn. In case of overdose, severe hypoglycemia can occur, requiring immediate emergency treatment including induced vomiting, gastric lavage, or intravenous glucose administration.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that allows minimal air exposure, preferably at a temperature between 1 degree and 30 degrees Celsius. It should also be used within 36 months from the manufacturing date to maintain effectiveness.
<Domestic> Green rectangular tablet, <Export> Green round tablet
30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Medica Korea Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.